Ready for an M&A fight? After GSK shunned $68B offer, Unilever says it's still in hunt for consumer health JV
So how much is the consumer healthcare business jointly owned by GlaxoSmithKline and Pfizer worth?
The answer is more than $68 billion, according to GSK …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
